VIRACTA THERAPEUTICS INC (VIRX) Stock News

Get insights into the top gainers and losers of Monday's after-hours session.

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Top movers in Monday's session

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Keep an eye on the top gainers and losers in Monday's session.

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

Traders are paying attention to the gapping stocks in Monday's session.

Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Stay updated with the stocks that are on the move in today's pre-market session.

Discover the top movers in Monday's pre-market session and stay informed about market dynamics.

12 Health Care Stocks Moving In Monday's Pre-Market Session

Why Triumph Group Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket

ServiceTitan initiated, Viracta downgraded: Wall Street's top analyst calls

ServiceTitan initiated, Viracta downgraded: Wall Street's top analyst calls

Viracta Therapeutics Announces Closure of NAVAL-1 Clinical Trial and Exploration of Strategic Alternatives

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the...

Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

- Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell...

Viracta Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the...

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024

VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Viracta Therapeutics (NASDAQ:VIRX) just reported results for the second quarter...

Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today?

Viracta Therapeutics stock is up on Wednesday alongside as VIRX investors react to its most recent earnings report and business updates.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!

Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

- Reported combined Stage 1 and Stage 2 results from the relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) cohort of the Phase 2...

Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan

- New combined Stage 1 and Stage 2 results from the relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) cohort of the Phase 2 NAVAL-1...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth checking out on Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!

Viracta Therapeutics Announces New Employment Inducement Grants

SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the...

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q1 2024

VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Viracta Therapeutics (NASDAQ:VIRX) just reported results for the first quarter ...

3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck

Although the concept of penny stocks under $1 is wildly speculative, these ideas could fly higher under the right circumstances.

Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the...